Filing search / Avenir Wellness Solutions, Inc. / "Litigation" / Page 2

8-K

EX-10.4

noels0 olf

28 Jul 22

CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million

9:51am

8-K/A

EX-99.1

nr7vbbn1 jaso0i2i5d

15 Dec 20

Financial Statements and Exhibits

9:15am

S-3

hbgwatmoc8ldcwagrx

30 Nov 20

Shelf registration

5:23pm

8-K

EX-10.1

52zr2xdq7o4

2 Nov 20

CURE Pharmaceutical Closes $10 Million Financing

4:05pm

8-K

EX-10.7

o6nrmbsmkbz50dl

2 Nov 20

CURE Pharmaceutical Closes $10 Million Financing

4:05pm

8-K

EX-2.1

p0a1lzi81 x3zn1

5 Oct 20

Entry into a Material Definitive Agreement

8:16am

8-K/A

EX-2.1

8b7dilk2

31 Dec 19

Completion of Acquisition or Disposition of Assets

12:15pm

8-K/A

EX-99.1

tjxd03x8

31 Dec 19

Completion of Acquisition or Disposition of Assets

12:15pm

CORRESP

unng3tus0nnrmkrd8l5b

26 Jun 19

Correspondence with SEC

12:00am